Literature DB >> 16544061

The importance of symptom assessment in the surgical treatment of gastroesophageal reflux disease and Barrett's esophagus.

J H Peters1.   

Abstract

The "art" and science of symptom assessment in the evaluation of patients with gastroesophageal reflux disease has been under emphasized. In fact, it is critical to judgements regarding surgical versus non-surgical therapy and is much more difficult than meets the eye. Many symptoms thought to be secondary to gastroesophageal reflux are not, and some, such as asthma cough and chest pain, which are commonly thought secondary to other causes, are indeed symptoms of reflux. Diagnostic studies are helpful but far from perfect, ultimately requiring the clinician's expert judgement as the key factor in determining a successful outcome. The following outlines both an approach to the assessment of symptoms and when possible, clinical studies shedding light on their cause and interpretation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16544061     DOI: 10.1007/s00464-006-0041-4

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  40 in total

1.  Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication.

Authors:  G M Campos; J H Peters; T R DeMeester; S Oberg; P F Crookes; S Tan; S R DeMeester; J A Hagen; C G Bremner
Journal:  J Gastrointest Surg       Date:  1999 May-Jun       Impact factor: 3.452

2.  EXPERIMENTAL REFERRED PAIN FROM THE GASTRO-INTESTINAL TRACT. PART I. THE ESOPHAGUS.

Authors:  W S Polland; A L Bloomfield
Journal:  J Clin Invest       Date:  1931-08       Impact factor: 14.808

3.  Gastroesophageal reflux disease and mucosal injury with emphasis on short-segment Barrett's esophagus and duodenogastroesophageal reflux.

Authors:  S Oberg; M P Ritter; P F Crookes; M Fein; R J Mason; M Gadensytätter; C G Brenner; J H Peters; T R DeMeester
Journal:  J Gastrointest Surg       Date:  1998 Nov-Dec       Impact factor: 3.452

4.  Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model.

Authors:  R C Fitzgerald; M B Omary; G Triadafilopoulos
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

5.  Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux.

Authors:  H J Stein; A P Barlow; T R DeMeester; R A Hinder
Journal:  Ann Surg       Date:  1992-07       Impact factor: 12.969

6.  Sustained esophageal contraction: a motor correlate of heartburn symptom.

Authors:  N Pehlivanov; J Liu; R K Mittal
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-09       Impact factor: 4.052

7.  The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure.

Authors:  S Oberg; T R DeMeester; J H Peters; J A Hagen; J J Nigro; S R DeMeester; J Theisen; G M Campos; P F Crookes
Journal:  J Thorac Cardiovasc Surg       Date:  1999-03       Impact factor: 5.209

8.  Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus.

Authors:  D A Katzka; D O Castell
Journal:  Am J Gastroenterol       Date:  1994-07       Impact factor: 10.864

9.  Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data.

Authors:  W K Hirota; T M Loughney; D J Lazas; C L Maydonovitch; V Rholl; R K Wong
Journal:  Gastroenterology       Date:  1999-02       Impact factor: 22.682

10.  Implication of duodenogastric reflux in the pathogenesis of Barrett's oesophagus.

Authors:  P Gillen; P Keeling; P J Byrne; M Healy; R R O'Moore; T P Hennessy
Journal:  Br J Surg       Date:  1988-06       Impact factor: 6.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.